You are here

  • Home
  • Archive
  • Volume 7, Issue 8
  • Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA

Article metrics

Article menu

Download PDFPDF

XML
Epidemiology
Research
Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201822223
Feb 201819176
Mar 201832306
Apr 201812124
May 201834348
Jun 201859607
Jul 201825254
Aug 201821219
Sep 201810100
Oct 201817173
Nov 2018222216
Dec 201812116
Jan 201919191
Feb 201924249
Mar 2019151511
Apr 2019181919
May 201921184
Jun 2019212110
Jul 201922226
Aug 201918185
Oct 201916178
Nov 201914145
Dec 201921195
Jan 202021163
Feb 202052488
Mar 202015129
May 20205510
Jun 2020881
Jul 2020996
Aug 2020973
Sep 202016162
Oct 202010102
Nov 202014148
Dec 202033337
Jan 202118154
Feb 202125244
Mar 202132329
Apr 202146458
May 202121217
Jun 2021262610
Jul 2021797916
Aug 202110108
Sep 202123224
Oct 2021343217
Nov 20215517
Dec 202121206
Jan 2022101017
Feb 2022141434
Mar 2022333416
Apr 202245444
May 2022778
Jun 202214144
Jul 202212123
Aug 202216147
Sep 2022548
Oct 202214146
Nov 2022171517
Dec 2022984
Jan 2023993
Feb 202315163
Mar 202311112
Apr 202313136
May 202311106
Jun 202310103
Jul 2023663
Aug 2023121214
Sep 2023141412
Oct 202312126
Nov 202327282
Dec 202331315
Jan 202491027
Feb 2024657
Mar 2024202060
Apr 2024111131
Total14391404642